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SUMMARY
Low lipid levels have been found in some studies to be associated with non-illness deaths (i.e. suicides, homicides and
accidents). Likewise, low lipids have been associated with measures of emotional distress (e.g. anxiety, depression,
hostility) in medical, psychiatric and forensic populations whose age, health status and/or personal habits make
interpretation of the association problematic. The present study examined the relationship of lipid levels to emotional
distress in young, healthy, male college students. To investigate possible confounding/mediating relationships, a
number of clinical risk factors and demographic variables were also studied (age, drug use, alcohol use, nicotine use,
exercise, obesity and resting hemodynamic values). Bivariate correlations showed that measures of emotional distress
(SCL-90-R subscales, Toronto Alexithymia Scale) and clinical/demographic factors (alcohol use, age, blood
pressure, weight and heart rate) were associated with lipid levels. In a hierarchical set multiple regression, only
alcohol use, age, resting systolic blood pressure and the positive symptom total from the SCL-90-R were unique
correlates of total cholesterol. These results add additional support to the growing evidence of an association
between lipid levels and emotional functioning. Importantly, this relationship appears to exist apart from other risk
factors. While various studies have focused on speci®c dimensions of emotional distress (i.e. anxiety, depression,
hostility), the results of the present study suggest that more global measures of emotional distress might better
account for the association with lipid levels. Copyright # 1999 John Wiley & Sons, Ltd.
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The therapeutic eect of reduced cholesterol on the
progression of cardiovascular disease has been well
established.1,2 However, several observational stu-
dies and longitudinal, prospective treatment studies
have found that overall mortality is not signi®-
cantly reduced.3±6 Interestingly, some data suggest
that reductions in fatal cardiovascular events are
partially oset by several types of non-illness death
(i.e. suicides, homicides and accidents). This con-
troversial ®nding is further supported by a negative
relationship between lipid levels and emotional
distress variables (i.e. anxiety, depression, hostil-
ity).7±13 The negative association between lipids
and emotional distress has been found in studies of
forensic patients,14±17 psychiatric patients,7,10,11
heart diseased patients,9 and the general popula-
tion.18±20 These data are also drawn from a broad
range of geographic regions and diverse
cultures.19±21
Importantly, the ®ndings noted above are not
particularly consistent, and a number of studies
have either failed to ®nd this relationship or found
the opposite relationship (i.e. as emotional distress
increased, so did lipid levels).22±28 For example,
elevations of lipid levels have been reported in
distressed individuals or during exposure to acute
stressors.29±38 In some cases these results may
re¯ect acute metabolic changes (e.g. decreased
plasma volume) that accompany acute emotional
arousal.39 On the other hand, chronically low
baseline cholesterol levels may have deleterious
CNS eects,40 and have been found in animal
studies to increase aggression.41 Three large treat-
ment studies have failed to ®nd increased non-
illness deaths or signi®cant emotional distress in
their treatment arms. However, they also have
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methodological limitations relevant to this matter.
For example, in some cases emotional status was
not assessed in a standardized manner.26 Inclusion/
exclusion procedures in some studies (i.e. The West
of Scotland study42; Weidner et al.28) confounded
compliance with subject selection and intervention
respectively. Since non-compliance is associated
with psychiatric distress and substance abuse, both
of these studies may have excluded relevant
subgroups for addressing the non-illness death
eect.
A number of questions have been raised regard-
ing the relationship of lipid levels to emotional
distress.43±45 For example, are speci®c lipid sub-
fractions (i.e. LDL, HDL, triglycerides) respons-
ible for this eect?19,21,46 Does the relationship hold
up in an essentially young and healthy population?
Recently Horsten et al.8 studied the relationship
between lipid levels and depressive symptoms in
healthy middle-aged women and found that low
serum cholesterol was associated with depressive
symptomatology. Often emotional status is as-
sessed in a limited fashion (i.e. narrow band
assessment) and as such may not capture the
range of negative emotional states that relate to
lipid levels. Finally, temporal contiguity between
the variable of interest (e.g. history of crime,
suicide, accident, depression) and cholesterol as-
sessment has often been lengthy. Therefore, studies
attempting to link current lipid levels with `history
of' behaviors are subject to a number of interven-
ing variables that limit causal value.
The present study sought to examine the
relationship of several measures of naturally occur-
ring lipid levels (i.e. total cholesterol, triglycerides,
LDL, HDL) with current emotional status in a
sample of young, healthy, male college students
using both narrow and broad band assessment
instruments of emotional distress and coping.
Several of the measures used in this study were
chosen as psychometrically sound clinical instru-
ments that bear some theoretical and/or empirical
relationship to cardiovascular disease (e.g. hosti-
lity, alexithymia). Clinical/demographic variables
of potential relevance to cholesterol, and thus
possible mediating/confounding variables, were
also examined in order to better establish the
unique relationship of emotional distress to chol-
esterol levels apart from other risk factors. It was
hypothesized that some of the emotional distress
assessment measures would show a statistically
unique negative relationship to total serum chol-
esterol. The relationship to lipid subfractions was
also investigated, but a priori hypotheses were not
generated as this was considered exploratory.
METHODOLOGY
Subjects
Seventy-six male university students were
initially recruited for participation. Eleven subjects
(15 percent) did not complete the entire research
protocol. One subject was dropped as an age
outlier. Exclusion criteria included diabetes, hyper-
tension, hypercholesterolemia or previous psychi-
atric history. One subject was dropped after
admitting that he was being treated for hypercho-
lesterolemia (i.e. lab values indicated total choles-
terol of 297 and triglyceride level of 860), leaving a
®nal sample of 63 subjects. The ®nal sample
represents a group of essentially healthy young
males. The mean age was 20.03 years with a range
from 18 to 24 years. Fifty-nine subjects identi®ed
themselves as Caucasian (93 percent), three as
African American (5 percent) and one as Hispanic
(2 percent). Relevant demographic and risk vari-
ables are presented in Table 1 and appear to
indicate an active group of young adults with
cholesterol levels falling well within accepted
medical guidelines.
Instrumentation
The Cook Medley Hostility Scale47 is a 50-item
scale derived from the Minnesota Multiphasic
Personality Inventory (MMPI), which has been
shown to predict risk for development of coronary
heart disease.48,49 The scale is thought to operatio-
nalize a number of constructs relevant to hostility
and has demonstrated good convergent, discrimi-
native and predictive validity.
The Symptom Checklist 90-Revised (SCL-90-
R)50 is a multidimensional self-report instrument
developed to assess a broad band of psychiatric
symptomatology and is widely used in clinical
practice and research. The checklist provides scores
on nine psychological dimensions (i.e. somatiza-
tion, obsessive-compulsive, interpersonal sensitiv-
ity, depression, anxiety, hostility, phobic anxiety,
paranoid ideation, psychoticism) and three general
indices (global severity index, positive symptom
distress index and positive symptom total). This
instrument was applied to assess gross psychiatric
symptomatology and a variety of psychiatric
manifestations of emotional distress.
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Alexithymia is a construct that re¯ects an indi-
vidual's diculty in recognizing and verbalizing
emotional states. Alexithymia has a theoretical and
empirical relationship to somatic illness.51 The
Toronto Alexithymia Scale (TAS)52 was con-
structed as a psychometrically sound measure of
the alexithymia construct based on a combination
of empirical and theoretical rationales. The scale is
composed of the following four factor analytically
derived subscales: (1) diculty identifying and dis-
tinguishing bodily sensations and feelings; (2) di-
culty describing feelings; (3) reduced daydreaming;
and (4) externally oriented thinking. The scale has
shown `adequate' reliability and validity.53±55
Blood serum assays were enzymatically analyzed
with a Boehringer Mannheim/Hatachi 704 analy-
zer following the manufacturers' protocol for total
serum cholesterol, triglycerides and high-density
lipoproteins using absorbance measurements.
Low-density lipoproteins were estimated using the
Friedewald equation (LDL  total cholesterolÿ
triglycerides/5  HDL). Lipid subfractions were
derived in order to explore the possibility that one
or more of these indices may bear a relationship to
measures of emotional distress.
Procedures
Phase I. Following initial recruitment and
informed consent, subjects completed the battery
of self-report measures including the Cook-Medley
Hostility Scale, SCL-90-R and Toronto Alexithy-
mia Scale. The ®rst phase of the study was com-
pleted after subjects were given oral and written
instruction for completing Phase II.
Phase II. Subjects reported to the university
health services laboratory within 48 hours of
Phase I to have height and weight measured,
blood pressure taken and to provide a blood
sample (the consent form included an outline of
the potential risks and bene®ts of a venipuncture
procedure). Venipuncture was performed using a
#21 needle following standard venipuncture pro-
tocol by a certi®ed medical technologist employed
at the health services center. Blood draws were
conducted between the hours of 8.00 am and
12 noon following a 12±14-hour fast. Ten milliliters
of venous blood were obtained for testing and
analyzed by the phlebotomy lab at a local
community hospital.
RESULTS
The means and standard deviations for the
psychometric dependent measures are provided in
Table 2. Bivariate tests of association (Pearson
product±moment correlation coecients) were run
between the lipid values (i.e. total cholesterol,
triglycerides, LDL, HDL) with the demographic
and risk variables, and the emotional distress
measures. There were no meaningfully signi®cant
correlations of any variable with the lipid subfrac-
tions. The clinical/demographic factors signi®-
cantly (p5 0.05 or less) associated with total
cholesterol included alcohol use (0.47), age (0.44),
weight (0.29), resting systolic blood pressure (0.27)
and resting heart rate (0.27). These variables are
commonly accepted risk factors for cardiovascular
disease. Among the psychometric measures, several
indices from the SCL-90-R (positive symptom
total, ÿ0.30 and paranoid ideation, ÿ0.26), and
scale 2 of the Toronto Alexithymia Scale (ÿ0.29)
were negatively associated with total cholesterol.
The positive symptom total summary scale re¯ects
the frequency of distressing symptoms, and para-
noia concerns a projection of hostility and suspi-
ciousness about the motives and intentions of
others. Scale 2 from the TAS concerns the inability
to label aective states in oneself. Importantly,
these bivariate associations were not corrected for
Table 1 Ð Means and standard deviations for clinical
and demographic variables
Variable Mean SD
Age (yr) 20 1.8
Body mass index 25.7 4.2
Resting heart rate (BPM) 65.4 13.6
RSBP 120.1 10.1
RDBP 73.5 6.5
Exercise (half hours per week) 15.9 16.2
Alcohol use (drinks per week) 8.2 8.3
Caeine use (cups of coee/tea, cans/
glasses/bottles of pop per day)
3.4 6.5
Nicotine (cigarettes/cigars/chews/
pipes full per day)
0.8 1.7




RSBP, resting systolic blood pressure; RDBP, resting diastolic
blood pressure; LDL, low density lipoprotein; HDL, high
density lipoprotein.
Note: Lipid values are provided in mg/dl.
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repeated signi®cance testing and are therefore
subject to Type I error in¯ation.
In order to determine the unique relationship of
the variables with signi®cant bivariate correlations
to total cholesterol and control for Type I error, a
hierarchical set regression using total cholesterol as
the criterion was employed. The solution for the
regression equation is shown in Table 3. The ®rst
set was de®ned using the signi®cant demographic/
risk factors (i.e. age, alcohol use, weight, resting
systolic blood pressure, resting heart rate) in order
to statistically control for these variables. The
second set included the emotional distress measures
with signi®cant bivariate associations (i.e. paranoia
and positive symptom total subscales of the
SCL-90-R, and Scale 2 of the TAS). Variables
within the two sets were entered in a stepwise
fashion. While it is acknowledged that stepwise
entry capitalizes on chance, it was decided that
clinical pragmatism and the exploratory nature of
our a priori questions dictated ®nding the best
predictive solution. In addition, the hierarchical set
approach is a more conservative strategy and
partially corrects for the more liberal aspect of
stepwise entry. An R2 adjusted for shrinkage is also
provided in Table 3. Predictor variables with the
strongest residual relationship (largest beta) were
entered if the p value was less than or equal to 0.05.
Previously entered predictor variables were re-
moved if the adjusted p value was greater than
0.10. Interestingly, the hierarchical set regression
equation made use of age, alcohol use, resting
systolic blood pressure (RSBP) and SCL-90-R
positive symptom total as the only signi®cant
predictors of total cholesterol. The ®nal model
including alcohol use, age, RSBP and positive
symptom total accounted for 48 percent of the
variance in this sample's total cholesterol scores
(R2  0.484). The beta weights were positive for
the ®rst three predictors, indicating that greater
alcohol use, older age and higher RSBP are associ-
ated with increased total cholesterol. However,
positive symptom total displayed a negative beta
weight, indicating that increasing frequency of
psychological symptoms is strongly and indepen-
dently associated with lower total serum cholester-
ol. Importantly, while positive symptom total only
accounted for approximately 7 percent of the
variance, this is after controlling for the other
associated variables.
DISCUSSION
These data lend additional support to the notion
that there is a relationship between total cholesterol















Toronto Alexithymia Scale 58.86 10.87
TAS 1 18.00 4.76
TAS 2 19.03 5.78
TAS 3 11.40 3.35
TAS 4 13.59 3.56
Cook-Medley Hostility Scale 22.89 7.87
Note: GSI, Global severity index; PSDI, positive symptom
distress index; PST, positive symptom total; TAS, Toronto
Alexithymia Scale.
Table 3 Ð Multiple regression predicting total cholesterol from clinical/demographic and psychometric variables
which yielded signi®cance in the bivariate tests
Variable B Beta R2 change F change Signi®cance
Alcohol 0.31 0.45 0.22 17.02 0.001
Age 6.55 0.33 0.15 14.18 0.001
RSBP 0.56 0.17 0.05 5.05 0.03
PST ÿ0.42 ÿ0.27 0.07 7.53 0.008
RSBP, Resting systolic blood pressure; PST, positive symptom total.
Note: Multiple R  0.70; R2  0.49; adjusted R2  0.45.
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level and some measures of emotional distress.
Importantly, this study replicates the negative
relationship between cholesterol and emotional
distress in a young, active and essentially healthy
male sample without demonstrable cardiovascular
disease or related medical risk factors (e.g. essential
hypertension). The relationship did not, however,
hold up for any of the lipid subfractions (LDL,
HDL, triglycerides). The strong relationships
between alcohol use, age and RSBP and total
cholesterol are consistent with previous ®ndings
and represent commonly accepted clinical corre-
lates of cardiac care.56 This ®nding also lends
credence to the validity of the sample and the
methodology. It is somewhat surprising to ®nd age
such a powerful predictor of total cholesterol given
that the age variable in this sample was so
truncated. Perhaps late adolescence/early adult-
hood is a period of change in cholesterol metab-
olism? It is somewhat interesting to note the unique
contribution of a more global index of distress. The
positive symptom total index re¯ects the frequency
of self reported psychological distress symptoms.
Given this was the only measure of emotional
distress to be retained in the hierarchical regression
equation (along with age), it may be that more
general measures of emotional distress better
account for the heterogeneity of negative psycho-
logical sequelae associated with low lipid levels.
This may also partially account for the mixed
®ndings in the literature such that the precise
emotional manifestation of low lipid levels is
mediated by as yet unidenti®ed mediating vari-
ables. Therefore, studies employing only a narrow
band assessment of emotional status may miss
identi®cation of this relationship.
The correlational nature of these data is a
limiting factor. This is true for most of the studies
cited, but when taken together with published
clinical trials examining non-illness death,44 they
provide a provocative stimulus but no ®rm
conclusions. Further, the relevance of gender was
not addressed here and remains an essentially
unexplored aspect of this controversial literature.
Additional research is indicated in order to obtain
a more thorough understanding of this association
and establish more causal relationships. Future
studies might monitor healthy normals and clinical
cases prospectively for changes in both mood and
behavior during the use of antilipidemic medi-
cations, or during clinically or experimentally
imposed diet changes. The use of standard reversal
designs (i.e. ABA) is ideal for this type of test.
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